Cargando…
Adverse cardiac events to monoclonal antibodies used for cancer therapy: The risk of Kounis syndrome
Monoclonal antibodies are currently used in the treatment of neoplastic, hematological, or inflammatory diseases, a practice that is occasionally associated with a variety of systemic and cutaneous adverse events. Cardiac adverse events include cardiomyopathy, ventricular dysfunction, arrhythmias, a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203633/ https://www.ncbi.nlm.nih.gov/pubmed/25340003 http://dx.doi.org/10.4161/onci.27987 |